Olin (OLN) Stock Looks Cheap While The Market Stays Cautious

Olin stock has been under clear pressure in recent years, yet the valuation checks currently lean cheap relative to the broader market. With the share price weak and sentiment tested by operational issues and legal scrutiny, investors are weighing whether the current level already reflects those concerns.

• Olin has fallen about 64.1% over the past 3 years, which puts the stock firmly in a recovery camp rather than a recent winner.
• The planned all stock merger with Huntsman can reshape the combined chemicals business and may support earnings power. However, the ongoing securities investigation highlights legal and operational risks that could still affect how investors price that potential.
• On a broad set of valuation checks Olin screens as relatively cheap, with a high value score of 6 that points to a stock the market may be pricing cautiously versus its fundamentals.

The issue now is whether Olin’s current share price offers enough compensation for the recent setbacks and merger execution risks that lie ahead.

Compare Olin’s current reset with other beaten down opportunities by scanning the hand-picked 45 high quality undervalued stocks that share similar value focused traits.

Is Olin Still Cheap on Sales?

P/S is a useful check for Olin because its revenue base can be compared across chemicals peers even when earnings are noisy.

Olin trades on a P/S ratio of about 0.3x, which is well below the Chemicals industry average of roughly 1.2x and a peer average of about 1.3x. The fair P/S ratio implied by the valuation model is 0.7x, which is more tailored to Olin’s size, margins and risk profile than a simple sector average. On this basis the current multiple sits significantly under that fair level, indicating that the stock is being priced cautiously relative to its sales.

The securities investigation and the impact of the Freeport plant shutdown on recent earnings mean investors are focused on near term risks. At the same time, the low P/S ratio still places Olin at a notable discount to sector norms, which is a market-based signal that the stock is being valued cheaply relative to the revenue it generates.

On the P/S multiple, Olin appears undervalued compared with both its modelled fair ratio and typical Chemicals peers.

See what the numbers say about this price — find out in our valuation breakdown.

The Olin Narrative: What Would Justify Today’s Price?

Simply Wall St Narratives for Olin pick up where the valuation checks stop by spelling out which paths for Olin’s future revenue, margins and earnings would need to hold for the stock to be worth materially more or less than today’s price, based on current information. Where a single ratio or model output gives one number, these scenarios aim to clarify the underlying assumptions so you can watch how Olin’s actual progress compares over time on the Community page.

One of the top community narratives on Olin: 38% undervalued

“Company wide acceleration of cost reductions, automation, and productivity initiatives, outpacing original targets, position Olin to generate meaningfully higher free cash flow and EPS…”

Read one of the top narratives on Olin

Do you think there’s more to the story for Olin? Head over to our Community to see what others are saying!

The Bottom Line

For Olin, the key takeaway is that the stock screens as undervalued on market multiples, especially relative to sales. That discount reflects real concerns around legal scrutiny and execution on the Huntsman merger rather than a simple mispricing. The crux for investors is whether those risks ease and allow the multiple to move closer to peers, or whether ongoing operational and legal setbacks mean the current discount is closer to fair. The debate now largely comes down to whether Olin can deliver more stable performance without fresh negative surprises.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com